Overall survival with darolutamide vs placebo in combination with androgen-deprivation therapy and docetaxel by stratification factors in the phase 3 ARASENS trial

Bertrand Tombal; Maha Hussain; Fred Saad; Karim Fizazi; Cora Sternberg; E David Crawford; Evgeny Kopyltsov; Arash Rezazadeh  Kalebasty; Boris Alekseev; Álvaro Montesa-Pino; Dingwei  Ye; Francis Parnis; Cruz Felipe Melo; Teuvo Tammela; Hiroyoshi Suzuki; Heikki Joensuu; Silke Thiele; Rui Li; Iris Kuss; Matthew R. Smith

Overall survival with darolutamide vs placebo in combination with androgen-deprivation therapy and docetaxel by stratification factors in the phase 3 ARASENS trial

Bertrand Tombal
, Maha Hussain
, Fred Saad
, Karim Fizazi
, Cora Sternberg
, E David Crawford
, Evgeny Kopyltsov
, Arash Rezazadeh Kalebasty
, Boris Alekseev
, Álvaro Montesa-Pino
, Dingwei Ye
, Francis Parnis
, Cruz Felipe Melo
, Teuvo Tammela
, Hiroyoshi Suzuki
, Heikki Joensuu
, Silke Thiele
, Rui Li
, Iris Kuss
, Matthew R. Smith

Research output: Other conference contribution › Abstract › Scientific

Original language	English
Publication status	Published - 4 Jul 2022
Publication type	Not Eligible
Event	EAU22 - Amsterdam, Netherlands Duration: 1 Jul 2022 → 4 Jul 2022 https://eaucongress.uroweb.org/scientific-programme/

Conference

Conference	EAU22
Country/Territory	Netherlands
City	Amsterdam
Period	1/07/22 → 4/07/22
Internet address	https://eaucongress.uroweb.org/scientific-programme/

Access to Document

https://prostate.uroonco.uroweb.org/webcast/overall-survival-with-darolutamide-versus-placebo-in-combination-with-androgen-deprivation-therapy-and-docetaxel-by-stratification-factors-in-the-phase-3-arasens-trial/

Cite this

Tombal, B., Hussain, M., Saad, F., Fizazi, K., Sternberg, C., Crawford, E. D., Kopyltsov, E., Kalebasty, A. R., Alekseev, B., Montesa-Pino, Á., Ye, D., Parnis, F., Felipe Melo, C., Tammela, T., Suzuki, H., Joensuu, H., Thiele, S., Li, R., Kuss, I., & Smith, M. R. (2022). Overall survival with darolutamide vs placebo in combination with androgen-deprivation therapy and docetaxel by stratification factors in the phase 3 ARASENS trial. Abstract from EAU22, Amsterdam, Netherlands. https://prostate.uroonco.uroweb.org/webcast/overall-survival-with-darolutamide-versus-placebo-in-combination-with-androgen-deprivation-therapy-and-docetaxel-by-stratification-factors-in-the-phase-3-arasens-trial/

@conference{73a8d80f611e43e48adadb0ce0ca1d70,

title = "Overall survival with darolutamide vs placebo in combination with androgen-deprivation therapy and docetaxel by stratification factors in the phase 3 ARASENS trial",

author = "Bertrand Tombal and Maha Hussain and Fred Saad and Karim Fizazi and Cora Sternberg and Crawford, \{E David\} and Evgeny Kopyltsov and Kalebasty, \{Arash Rezazadeh\} and Boris Alekseev and {\'A}lvaro Montesa-Pino and Dingwei Ye and Francis Parnis and \{Felipe Melo\}, Cruz and Teuvo Tammela and Hiroyoshi Suzuki and Heikki Joensuu and Silke Thiele and Rui Li and Iris Kuss and Smith, \{Matthew R.\}",

year = "2022",

month = jul,

day = "4",

language = "English",

note = "EAU22 ; Conference date: 01-07-2022 Through 04-07-2022",

url = "https://eaucongress.uroweb.org/scientific-programme/",

}

Tombal, B, Hussain, M, Saad, F, Fizazi, K, Sternberg, C, Crawford, ED, Kopyltsov, E, Kalebasty, AR, Alekseev, B, Montesa-Pino, Á, Ye, D, Parnis, F, Felipe Melo, C, Tammela, T, Suzuki, H, Joensuu, H, Thiele, S, Li, R, Kuss, I & Smith, MR 2022, 'Overall survival with darolutamide vs placebo in combination with androgen-deprivation therapy and docetaxel by stratification factors in the phase 3 ARASENS trial', EAU22, Amsterdam, Netherlands, 1/07/22 - 4/07/22. <https://prostate.uroonco.uroweb.org/webcast/overall-survival-with-darolutamide-versus-placebo-in-combination-with-androgen-deprivation-therapy-and-docetaxel-by-stratification-factors-in-the-phase-3-arasens-trial/>

TY - CONF

T1 - Overall survival with darolutamide vs placebo in combination with androgen-deprivation therapy and docetaxel by stratification factors in the phase 3 ARASENS trial

AU - Tombal, Bertrand

AU - Hussain, Maha

AU - Saad, Fred

AU - Fizazi, Karim

AU - Sternberg, Cora

AU - Crawford, E David

AU - Kopyltsov, Evgeny

AU - Kalebasty, Arash Rezazadeh

AU - Alekseev, Boris

AU - Montesa-Pino, Álvaro

AU - Ye, Dingwei

AU - Parnis, Francis

AU - Felipe Melo, Cruz

AU - Tammela, Teuvo

AU - Suzuki, Hiroyoshi

AU - Joensuu, Heikki

AU - Thiele, Silke

AU - Li, Rui

AU - Kuss, Iris

AU - Smith, Matthew R.

PY - 2022/7/4

Y1 - 2022/7/4

M3 - Abstract

T2 - EAU22

Y2 - 1 July 2022 through 4 July 2022

ER -